跳至主要内容
临床试验/ACTRN12626001035314
ACTRN12626001035314招募中不适用

Development of an AI-guided approach to markerless tracking of abdominal targets and organs-at-risk (OARs) during radiotherapy

Northern Sydney Local Health District0 个研究点目标入组 20 人开始时间: 2026年5月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 No limit(—)
性别
All

入选标准

  • Receiving upper abdominal radiotherapy (pancreas, liver, kidney, adrenal gland) with a planning CT scan. If the site of treatment is not the pancreas, at least one of the specified organs-at-risk (duodenum, small bowel, stomach) must be present within a 2 cm margin of the planning target volume.

排除标准

  • Tumour maximum dimension more than 12 cm and minimum dimension less than 1 cm, unable to give informed consent and/or pregnant women.

研究者

相似试验